Xolair 150 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FL2C1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,948
Award facts
- Contract value 100% obligated
- $30,948.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $30,948.00 to DMS Pharmaceutical Group Inc. for Xolair 150 mg/ml syringes. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Park Ridge location with an ultimate completion date of October 20, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, allowing the contractor to leverage its capabilities in the competitive federal marketplace.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, which carries a ceiling value of $499,999,999 and extends through November 2026. The IDC enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting Department of Defense healthcare facilities worldwide. Xolair, a biologic medication used primarily for severe asthma and chronic urticaria treatment, represents one of the specialized pharmaceutical products within the contract's extensive portfolio of branded and generic prescription drugs, biologics, and medical consumables distributed to military health facilities.
Quick answers
Who was awarded contract SPE2DB25FL2C1?
SPE2DB25FL2C1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FL2C1 worth?
The government has obligated $30,948 on SPE2DB25FL2C1.
Is contract SPE2DB25FL2C1 an order under another contract?
Yes. SPE2DB25FL2C1 is a delivery order under SPE2DB20D9331, an indefinite delivery contract.
Was contract SPE2DB25FL2C1 competed?
The extent of competition for SPE2DB25FL2C1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award